MANNHEIM, Germany, January 12 /PRNewswire/ -- MIDAS Research has
published a research report on the nanotechnology company Arrowhead Research
Corp. (Nasdaq: ARWR / Berlin Exchange: HDP) with a 12 month target of USD
6.00 and a speculative buy recommendation. A copy of the report is available
in both German and English at www.midasresearch.de .
Arrowhead Research is developing products and intellectual property in a
number of nanotech fields including novel drug delivery systems,
semiconductor materials and tools for atomic force microscopy.
As judged by the breadth and diversity of Arrowheads intellectual
property the company is likely to gain much broader attention by investors
concludes MIDAS Research technology analyst Karsten Siebert, CEFA, in his
MIDAS Research is an independent stock research company with a global
focus on emerging industries like nanotech and biotech. Recent reports have
successfully highlighted stocks like MorphoSys (GER), pSivida (AUS), Callisto
Pharma (USA) or EpiTan (AUS).
For further information please contact:
SOURCE MIDAS Research